Bupivacaine Versus Bupivacaine Plus Lidocaine in Infraclavicular Block

• Status: Not yet recruiting
• Trial end date: 2023-12-01
• Target enrollment: 0
• Participant gender: All

Summary

In this study, the investigators will compare two different anesthetic solutions in the infraclavicular block in patients having forearm, wrist, and hand surgery. The solutions will be bupivacaine 0.5% versus bupivacaine 0.25% plus lidocaine 1%, both associated with epinephrine 5 mcg/ml and dexamethasone 4 mg.

The main objective of this investigation is to demonstrate that using higher concentrations of bupivacaine alone results in a significant block duration increase compared with the mixture of bupivacaine and lidocaine.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hospital de San Carlos Dr. Benicio Arzola Medina
• Treatments: Bupivacaine; Lidocaine

Criteria

Inclusion Criteria:

• Age between 18 and 80 years

• American Society of Anesthesiologists classification 1-3

• Elective surgery of the forearm, wrist, and hand

• Weight ≥ 80 kilograms

Exclusion Criteria:

• Adults who are unable to give their consent

• Infection in the injection site (infraclavicular region)

• Pre-existing neuropathy (assessed by history and physical examination)

• Coagulopathy (assessed by history and physical examination and, if deemed clinically necessary, by blood work, i.e., platelets ≤ 100, International Normalized Ratio ≥ 1.4)

• Renal failure (assessed by history and physical examination and if deemed clinically necessary, by blood work, i.e., creatinine ≥ 1.2)

• Hepatic failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work, i.e., transaminases ≥ 100)

• Allergy to local anesthetics (LAs)

• Pregnancy or breastfeeding

• Prior surgery in the infraclavicular region

• Chronic pain syndromes requiring opioid intake at home